SCHEMBL30947397

SCHEMBL30947397

CC(C)c1n[nH]c2c(=O)[nH]c(Cc3cc(F)ccc3OCCN3CCOCC3)nc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 5/20 0.64
PDE1C Q14123 5/20 0.64
PDE1A P54750 4/20 0.64
PDE1B Q01064 4/20 0.64
PDE5A O76074 3/20 0.64
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41
ADORA2A P29274 2/20 0.40
FLT3 P36888 1/20 0.38
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 2/20 0.38
DRD1 P21728 1/20 0.38
DRD4 P21917 1/20 0.38
DRD5 P21918 1/20 0.38
P2RX7 Q99572 1/20 0.37
HTR2A P28223 2/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
KCNH2 Q12809 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5061553 1.00 PDE9A (0.64) PDE9APDE1CPDE1APDE1BPDE5A
Hydrochloric Acid SCHEMBL6864925 0.99 PDE9A (0.63) PDE9APDE1CPDE1APDE1BPDE5A
SCHEMBL30947390 0.90 PDE9A (0.77) PDE9APDE1CPDE1APDE1BPDE5A
SCHEMBL5064284 0.90 PDE9A (0.77) PDE9APDE1CPDE1APDE1BPDE5A
Hydrochloric Acid SCHEMBL6756650 0.90 PDE9A (0.76) PDE9APDE1CPDE1APDE1BPDE5A
SCHEMBL5065561 0.85 PDE9A (0.53) PDE9APDE1CPDE1APDE1BPDE5A
SCHEMBL30947399 0.85 PDE9A (0.53) PDE9APDE1CPDE1APDE1BPDE5A
Hydrochloric Acid SCHEMBL6756750 0.84 PDE9A (0.52) PDE9APDE1CPDE1APDE1BPDE5A
SCHEMBL5067596 0.82 PDE9A (0.65) PDE9APDE1CPDE1APDE1BPDE5A
SCHEMBL30947387 0.82 PDE9A (0.65) PDE9APDE1CPDE1APDE1BPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4618980-A1 ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES Freedom Biosciences, Inc. (US) 2025-09-24 EP claimed
WO-2024107445-A1 ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES FREEDOM BIOSCIENCES, INC. (US) 2024-05-23 WO claimed
EP-4618980-A1 ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES Freedom Biosciences, Inc. (US) 2025-09-24 EP disclosed
WO-2024107445-A1 ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES FREEDOM BIOSCIENCES, INC. (US) 2024-05-23 WO disclosed